Meeder Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-75
| Closed | -$15K | – | 2503 |
|
|
2020
Q1 | $15K | Buy |
75
+64
| +582% | +$12.8K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $3K | Sell |
11
-1
| -8% | -$273 | ﹤0.01% | 1948 |
|
|
2019
Q3 | $4K | Buy |
12
+3
| +33% | +$1K | ﹤0.01% | 1837 |
|
|
2019
Q2 | $4K | Sell |
9
-4
| -31% | -$1.78K | ﹤0.01% | 1746 |
|
|
2019
Q1 | $7K | Sell |
13
-3
| -19% | -$1.62K | ﹤0.01% | 1330 |
|
|
2018
Q4 | $5K | Buy |
16
+4
| +33% | +$1.25K | ﹤0.01% | 1424 |
|
|
2018
Q3 | $9K | Buy |
+12
| New | +$9K | ﹤0.01% | 1194 |
|